Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial.
- DOI
- 10.2147/opth.s278169
- Published
- 2021
- Container
- Clinical ophthalmology (Auckland, N.Z.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/opth.s278169,
title = {Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial.},
author = {Pepose JS and Hartman PJ and DuBiner HB and Abrams MA and Smyth-Medina RJ and Moroi SE and Meyer AR and Sooch MP and Jaber RM and Charizanis K and Klapman SA and Amin AT and Yousif JE and Lazar ES and Karpecki PM and Slonim CB and McDonald MB},
year = {2021},
journal = {Clinical ophthalmology (Auckland, N.Z.)},
doi = {10.2147/opth.s278169},
url = {https://doi.org/10.2147/opth.s278169}
}RIS
TY - JOUR TI - Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial. AU - Pepose JS AU - Hartman PJ AU - DuBiner HB AU - Abrams MA AU - Smyth-Medina RJ AU - Moroi SE AU - Meyer AR AU - Sooch MP AU - Jaber RM AU - Charizanis K AU - Klapman SA AU - Amin AT AU - Yousif JE AU - Lazar ES AU - Karpecki PM AU - Slonim CB AU - McDonald MB PY - 2021 JO - Clinical ophthalmology (Auckland, N.Z.) DO - 10.2147/opth.s278169 UR - https://doi.org/10.2147/opth.s278169 ER -
APA
JS, P., PJ, H., HB, D., MA, A., RJ, S., SE, M., AR, M., MP, S., RM, J., K, C., SA, K., AT, A., JE, Y., ES, L., PM, K., CB, S., & MB, M. (2021). Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial.. Clinical ophthalmology (Auckland, N.Z.). https://doi.org/10.2147/opth.s278169
Source records
- pubmed · retrieved 2026-11-10T11:53:11.818Z